Merck KGaA (XTER:MRK)
€ 154.5 -1 (-0.64%) Market Cap: 67.17 Bil Enterprise Value: 75.03 Bil PE Ratio: 23.96 PB Ratio: 2.53 GF Score: 89/100

Merck KGaA at JPMorgan Healthcare Conference Transcript

Jan 08, 2024 / NTS GMT
Release Date Price: €141.1 (-0.91%)
Richard Vosser
JPMorgan Chase & Co, Research Division - Senior Analyst

Good morning, everyone. Welcome to the Merck KGaA from Darmstadt, Germany presentation. I've got to get that clear. At the JPMorgan Healthcare Conference. I'm Richard Vosser, European pharma analyst with JPMorgan. It's my great pleasure to welcome the CEO, Belen Garijo, who is going to do the presentation. The Q&A is in this room. So we've got no problems with those logistics. So Belen, welcome to the conference.

Belen Garijo Lopez
Merck KGaA - Chair of Executive Board & CEO

Thank you very much. Thank you, Richard, and good morning, everyone. It's a pleasure to be here one more year, keeping the tradition of starting of the new year with the presentation at JPMorgan. So Happy New Year, everyone. I'm very pleased to be here.

So let me -- next, please. So let me start by stating and even, I would say, celebrating that we have left behind a very tough transition year in 2023. And now we are looking forward to the future with a strong confidence. And why is that? First of all

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot